Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genentech said the FDA approved Tecentriq, with safety information in the release noting possible fertility problems in females. The notice also referenced Tecentriq Hybreza and pointed readers to prescribing information and medication guides.
Genentech said the FDA approved Tecentriq and Tecentriq Hybreza in combination with a fluoropyrimidine and oxaliplatin for adjuvant treatment of a certain type of stage III colon cancer.